Advagene Biopharma Co., Ltd.
About Advagene
Milestone
Management Team
Board of Directors
R&D PIPELINE
NEW DRUG PEPLINE
Intranasal Vaccines
Airway allergy immunotherapy
Covid-19-immunitytherapy
Other vaccine applications
News
News
Press Releases
Partnerships and Collaborators
Investors
Catalogs
公開資訊觀測站
繁體中文
English
简体中文
Contact Us
Home
News
News
The phase II clinical trial of LT-Flu nasal Flu vaccine has been published in the Vaccine Journal(https://www.ncbi.nlm.nih.gov/pubmed/31812463)
The phase II clinical trial of LT-Flu nasal Flu vaccine has been published in the Vaccine Journal(https://www.ncbi.nlm.nih.gov/pubmed/31812463)
The
phase II clinical trial of LT-Flu nasal Flu vaccine
has been published in the
Vaccine Journal
(
https://www.ncbi.nlm.nih.gov/pubmed/31812463)
2019-11-18
Back
繁體中文
English
简体中文